Skip to content

The efficacy and peripheral mechanisms of ultrasound-guided injection adjacent to the brachial plexus with 5% glucose for upper limb edema in stroke patients:A randomized, double-blind, controlled trial

The efficacy and peripheral mechanisms of ultrasound-guided injection adjacent to the brachial plexus with 5% glucose for upper limb edema in stroke patients:A randomized, double-blind, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065147
Enrollment
Unknown
Registered
2022-10-29
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Experimental group:ultrasound-guided injection adjacent to the brachial plexus with 5% glucose and rehabilitation therapy
Control group:ultrasound-guided injection adjacent to the brachial plexus with physiological saline

Sponsors

The Sixth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In line with the diagnostic criteria for stroke formulated by the Fourth National Conference on Cerebrovascular Disease, the patient was confirmed as cerebral infarction or cerebral hemorrhage by transcranial CT or MRI examination 2. Disease course and condition: first onset, recovery period (1 month to 1 year), stable vital signs 3. Age: 18-80 years old 4. According to the International Society of Lymphatics criteria for limb edema, the affected hand was mild (edema volume increase of < 20%, heavy tightness and weakness of the limb) and moderate (edema volume) Increased 20%-40%, shiatsu depression) edema 5. The VAS score of hemiplegic upper limb pain was < 5 6. be able to listen, speak, read and understand Chinese; be able to understand the requirements of the study; be willing to cooperate with the study; and sign the informed consent voluntarily

Exclusion criteria

Exclusion criteria: 1. Diabetes, peripheral neuropathy or skin ulceration cannot be treated by injection; 2. Fracture history, trauma surgery history, thrombophlebitis history and infection history for hemiplegic upper limb; 3. History of other conditions that cause hand edema, such as mastectomy, nephrotic syndrome, albumin levels below 3.2 g per deciliter, liver cirrhosis, congestive heart failure, and complex areas pain syndrome; 4. Severe heart, lung, liver, renal insufficiency, tumor, blood diseases; 5. Cognitive dysfunction cannot cooperate with treatment; 6. Pregnancy or lactation; 7. Injection adjacent to the brachial plexus with 5% glucose was performed in the past month.

Design outcomes

Primary

MeasureTime frame
Volume measurement of carpal and hand edema;

Secondary

MeasureTime frame
Volume measurement of carpal and hand edema;pain;upper limber and hand function;basic activities of daily life;Instrumental activities of daily living;

Countries

China

Contacts

Public ContactJiang Li

The Sixth Affiliated Hospital of Sun Yat-sen University

jiangl26@mail.sysu.edu.cn15800045323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026